Year archive

Jamjoom Pharmaceuticals Factory Co. — 2026 filings

All 7 regulatory filings released by Jamjoom Pharmaceuticals Factory Co. (4015) in 2026, sourced directly from the official regulator.

7 Filings

2026 Period

2026 filings (7)

Filing	Released	Lang
Jamjoom Pharmaceuticals Factory Co. Board invites its shareholders to attend the Extraordinary General Assembly Meeting (First Meeting) via modern technology means Proxy Solicitation & Information Statement	2026-05-20	English
Jamjoom Pharmaceuticals Factory Co. Announces providing a corporate guarantee to its Joint Venture in Algeria Capital/Financing Update	2026-05-11	English
Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial results for the Period Ending on 2026-03-31 ( Three Months ) Earnings Release Q1 2026	2026-04-23	English
Jamjoom Pharmaceuticals Factory Co. announces the board of director’s decision to distribute cash dividends for Second half of 2025 (Six months) Notice of Dividend Amount	2026-02-24	English
Jamjoom Pharmaceuticals Factory Co. announces its Annual Financial results for the period ending on 31-12-2025 Earnings Release	2026-02-24	English
Jamjoom Pharmaceuticals Factory Co. Announces providing a corporate guarantee to its Joint Venture in Algeria Capital/Financing Update	2026-01-18	English
Jamjoom Pharmaceuticals Factory Co. announces the Board of Directors' recommendation to transfer the entire balance of the statutory reserve to retained earnings Regulatory Filings	2026-01-01	English